Covid vaccine

PFIZER officials announced on October 16 that the pharmaceutical giant won’t be ready to apply for FDA approval of its Covid19 vaccine until the third week of November.

That means there will be no miracle election day vaccine — which should assuage fears that this potentially lifesaving development might be prematurely rushed past scientific protocols for political ends.

A credible vaccine is needed, especially with coronavirus cases once again trending upward across the country.

However, to prevent the spread of the potentially deadly virus, any vaccine must not only be safe and effective, it must also be widely adopted. That’s not guaranteed given the swirl of fear and misinformation concerning the record pace of Operation Warp Speed, the federal effort to accelerate development, production and distribution of Covid19 treatments and vaccines.

Only about half the people responding to a recent Pew

Research Centre survey said they would definitely or probably get a coronavirus vaccine if it were available today. That’s down from 72% in May. More than threefourths of the survey respondents said they believed things were moving too fast: That a vaccine could be approved before its safety and effectiveness were fully understood.

Pfizer’s announcement takes the air out of electionrelated rumours, but more must be done to help reassure the nervous public that the accelerated timeline is not being pushed at the expense of safety.

Rarely has scientific development been the subject of such intense public scrutiny or scepticism. That demands unprecedented transparency and public education about scientific processes, too.